Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…